CharlesLavenderMD

PubMed

• 3 citations
  Co-existing inflammatory bowel disease and Barrett's esophagus is associated with esophageal dysplasia: a propensity score-matched cohort.
  Matthew Fasullo, Aditya Sreenivasen, Erik A. Holzwanger, Charles A. Lavender, Milan Patel
  Endoscopy International Open. 2021-09-16
• 2 citations
  Acute Liver Failure Due to Miliary Liver Metastasis
  Charles A. Lavender, Jessica Stout, Hui-Yong Chung, Michael Johnson, Ragesh B. Thandassery
  ACG Case Reports Journal. 2020-03-16
• Improving prognostication in patients with hepatocellular carcinoma undergoing loco-regional therapy using pre- and post-locoregional therapy scores.
  Ragesh B Thandassery, Charles A Lavender, Abhilash Perisetti, Michael Beheshti
  Abdominal Radiology. 2024-02-01

Journal Articles

• Improving prognostication in patients with hepatocellular carcinoma undergoing loco-regional therapy using pre- and post-locoregional therapy scores  
  Ragesh Thandassery; Charles A Lavender; Abhilash Perisetti; Michael Beheshti, Abdominal Radiology, 12/9/2023

Books/Book Chapters

• Atlas of Endoscopy Imaging in Inflammatory Bowel Disease 
  Chapter: Confocal endomicroscopy and other image-enhanced endoscopy in inflammatory bowel disease 
  Page 311 - 329Charles A. Lavender, Xuili Zuo, Marietta Iacucci, Bo Shen, and Julia J. LiuEditors: Bo Shen.Elsevier Inc. 2020

Abstracts/Posters

• Colonic Biopsy Pyroptosis Predicts Clinical Response to Vedolizumab in Crohnʼs Disease
  Lavender CA, Osterman MT, Gordon IO, Davis EM, Ciorba MA, Glover S, Abraham B, Yee EU, Allard FD, Young G, Shen B, Khan F, Claggett B, Guo Xueyan, Stappenbeck TS, & Li..., American College of Gastroenterology, San Antonio, TX, 10/2019
• Impact of Sarcopenia and Sarcopenic Obesity on Transplant-Free Survival in Patients with Hepatocellular Carcinoma Undergoing Locoregional Therapy
  Lavender CA, Perisetti A, Dranoff JA, Beheshti MV, & Thandassery RB, Oral Abstract Presentation - United European Gastroenterology (UEG) Week Conference, 10/2020
• Non-invasive Fibrosis Tests to Identify Advanced Liver Disease and Facilitate Referral to Specialty Clinics - A US Veteran Cohort Analysis
  Lavender CA, Askew E, Sharma T, Salah H, Perisetti A, Dranoff JA, Thandassery RB, United European Gastroenterology (UEG) Week Conference, 10/2020
• Non-invasive Fibrosis Tests (APRI, FIB-4, & NFS) to Identify Advanced Liver Disease and Facilitate Referral to Specialty Clinics - A US Veteran Cohort Analysis
  Lavender CA, Askew E, Sharma T, Salah H, Perisetti A, Dranoff JA, Thandassery RB, Digestive Disease Weekly (DDW) Conference, 5/2020
• Impact of Sarcopenia and Sarcopenic Obesity on Transplant-Free Survival in Patients with Hepatocellular Carcinoma Undergoing Locoregional Therapy
  Lavender CA, Perisetti A, Dranoff JA, Beheshti MV, & Thandassery RB, Digestive Diseases Weekly (DDW) Annual Conference, 5/2020
• Prognostication in Patients with Hepatocellular Carcinoma Undergoing Locoregional Therapy‐Refining Transplant Free Survival Beyond BCLC Staging
  Thandassery RB, Lavender CA, Rude K, Burdine L, & Beheshti M, American Association for the Study of Liver Diseases (AASLD), Boston, MA, 11/2019
• Predicting Transplant Free Survival in Patients With Hepatocellular Carcinoma Undergoing Locoregional Therapy
  Thandassery RB, Lavender CA, Rude K, Burdine L, Behesthi M, American College of Gastroenterology, San Antonio, TX, 10/2019
• Refractory GI Bleed: Old Drug Beats New Technology
  Charles Lavender & James Lopez, ACP National Internal Medicine Meeting, Philadelphia, PA, 4/2019
• Join now to see all